BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34332107)

  • 21. The PEP++ study protocol: a cluster-randomised controlled trial on the effectiveness of an enhanced regimen of post-exposure prophylaxis for close contacts of persons affected by leprosy to prevent disease transmission.
    Hinders DC; Taal AT; Lisam S; da Rocha AM; Banstola NL; Bhandari P; Saha A; Kishore J; Fernandes VO; Chowdhury AS; van 't Noordende AT; Mieras L; Richardus JH; van Brakel WH
    BMC Infect Dis; 2024 Feb; 24(1):226. PubMed ID: 38378497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design of the leprosy component of the Brazilian BCG revaccination trial for assessing BCG effectiveness against leprosy in school children.
    Cunha SS; Dourado I; Barreto ML; Alexander N; Pereira SM; Ichihara Y; Pereira ES; Pedrosa V; Maroja F; Ribas C; Rodrigues LC
    Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):8-15. PubMed ID: 15217320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic Effects of BCG Vaccination on Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Chang YC; Lin CJ; Hsiao YH; Chang YH; Liu SJ; Hsu HY
    J Diabetes Res; 2020; 2020():8954125. PubMed ID: 32309449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BCG-induced immunity profiles in household contacts of leprosy patients differentiate between protection and disease.
    van Hooij A; van den Eeden SJF; Khatun M; Soren S; Franken KLMC; Chandra Roy J; Alam K; Chowdhury AS; Richardus JH; Geluk A
    Vaccine; 2021 Dec; 39(50):7230-7237. PubMed ID: 34688497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BCG vaccine and leprosy household contacts: Protective effect and probability to becoming sick during follow-up.
    Gomes RR; Antunes DE; Dos Santos DF; Sabino EFP; Oliveira DB; Goulart IMB
    Vaccine; 2019 Oct; 37(43):6510-6517. PubMed ID: 31500969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interventions for preventing infection in nephrotic syndrome.
    Wu HM; Tang JL; Cao L; Sha ZH; Li Y
    Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD003964. PubMed ID: 22513919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravesical bacillus Calmette-Guerin versus mitomycin C for Ta and T1 bladder cancer.
    Shelley MD; Court JB; Kynaston H; Wilt TJ; Coles B; Mason M
    Cochrane Database Syst Rev; 2003; (3):CD003231. PubMed ID: 12917955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maintenance versus non-maintenance intravesical Bacillus Calmette-Guerin instillation for non-muscle invasive bladder cancer: A systematic review and meta-analysis of randomized clinical trials.
    Chen S; Zhang N; Shao J; Wang X
    Int J Surg; 2018 Apr; 52():248-257. PubMed ID: 29499363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of BCG in prevention of leprosy: a meta-analysis.
    Setia MS; Steinmaus C; Ho CS; Rutherford GW
    Lancet Infect Dis; 2006 Mar; 6(3):162-70. PubMed ID: 16500597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The BCG controversy: a reappraisal of the protective effect against tuberculosis and leprosy.
    Zodpey SP
    Indian J Public Health; 2004; 48(2):70-7. PubMed ID: 15709589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leprosy post-exposure prophylaxis with single-dose rifampicin (LPEP): an international feasibility programme.
    Richardus JH; Tiwari A; Barth-Jaeggi T; Arif MA; Banstola NL; Baskota R; Blaney D; Blok DJ; Bonenberger M; Budiawan T; Cavaliero A; Gani Z; Greter H; Ignotti E; Kamara DV; Kasang C; Manglani PR; Mieras L; Njako BF; Pakasi T; Pandey BD; Saunderson P; Singh R; Smith WCS; Stäheli R; Suriyarachchi ND; Tin Maung A; Shwe T; van Berkel J; van Brakel WH; Vander Plaetse B; Virmond M; Wijesinghe MSD; Aerts A; Steinmann P
    Lancet Glob Health; 2021 Jan; 9(1):e81-e90. PubMed ID: 33129378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Yavatmal District, India.
    Zodpey SP; Ambadekar NN; Thakur A
    Public Health; 2005 Mar; 119(3):209-16. PubMed ID: 15661132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy control.
    Merle CS; Cunha SS; Rodrigues LC
    Expert Rev Vaccines; 2010 Feb; 9(2):209-22. PubMed ID: 20109030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ILEP organisations should strive for high BCG coverage in communities at risk of leprosy.
    Velema JP; Ogbeiwi OI
    Lepr Rev; 2007 Jun; 78(2):88-101. PubMed ID: 17824479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemoprophylaxis is effective in the prevention of leprosy in endemic countries: a systematic review and meta-analysis. MILEP2 Study Group. Mucosal Immunology of Leprosy.
    Smith CM; Smith WC
    J Infect; 2000 Sep; 41(2):137-42. PubMed ID: 11023757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature.
    Colditz GA; Berkey CS; Mosteller F; Brewer TF; Wilson ME; Burdick E; Fineberg HV
    Pediatrics; 1995 Jul; 96(1 Pt 1):29-35. PubMed ID: 7596718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative leprosy vaccine trial in south India.
    Gupte MD; Vallishayee RS; Anantharaman DS; Nagaraju B; Sreevatsa ; Balasubramanyam S; de Britto RL; Elango N; Uthayakumaran N; Mahalingam VN; Lourdusamy G; Ramalingam A; Kannan S; Arokiasamy J
    Indian J Lepr; 1998; 70(4):369-88. PubMed ID: 10189587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-leprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: lepromin skin test results.
    Gormus BJ; Baskin GB; Xu K; Ratterree MS; Mack PA; Bohm RP; Meyers WM; Walsh GP
    Lepr Rev; 2002 Sep; 73(3):254-61. PubMed ID: 12449891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antileprosy protective vaccination of sooty mangabey monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.
    Gormus BJ; Baskin GB; Xu K; Ratterree MS; Martin LN; Mack PA; Bohm RP; Meyers WM; Walsh GP
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):434-43. PubMed ID: 11332286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.